eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2014
vol. 9
 
Share:
Share:
abstract:
Review paper

Ploidy and DNA index as prognostic factors in resected pancreatic ductal adenocarcinoma – a review of the literature

Marek Durlik
,
Julia Tuchalska-Czuroń

Prz Gastroenterol 2014; 9 (6): 313–316
Online publish date: 2014/12/30
View full text Get citation
 
PlumX metrics:
In Poland, pancreatic cancer is the seventh most common cause of cancer-related death amongst men and the sixth amongst women. Pancreatic cancer has an extremely poor prognosis. Radical surgery still remains the only way of curing pancreatic cancer, and this is possible to perform in just 20% of cases, i.e. those that present localised disease upon diagnosis. An average survival of ~20 months post-resection and adjuvant chemotherapy has been observed in 10–15% of patients with tumours limited to the pancreas at the time of presentation. It is necessary to define strong prognostic factors to determine individual treatment and prognosis. In this paper we submit a review of the literature concerning the prognostic impact of the ploidy and the DNA index on the survival of patients who underwent resection of pancreatic ductal adenocarcinoma. However, the presented studies have produced conflicting results. Pancreatic cancer still remains a great challenge in medicine.
keywords:

pancreatic cancer, ploidy, DNA index

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.